On Sept. 13, information about the results of a new Phase 3 Trial of MDMA-assisted therapy for PTSD treatment was published by the Multidisciplinary Association for Psychedelic Substances (MAPS). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results